Vanda Pharmaceuticals Inc.
$321.69M- Market cap
- $328.31M
- Debt
- +$78.23M
- Cash
- −$84.85M
Capital structure 81% equity / 19% debt · EV / Revenue 1.49x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
VNDA · current priceP/S 1.52x
$5.43Latest market snapshot
Implied fair value · at RBLX's multiple
$22.61316.4% above market
3.57 VNDA revenue / share×6.33x RBLX P/S=$22.61
Market $5.43Implied $22.61
RBLX · current priceP/S 6.33x
$43.31Latest market snapshot
Implied fair value · at VNDA's multiple
$10.7775.1% below market
7.09 RBLX revenue / share×1.52x VNDA P/S=$10.77
Market $43.31Implied $10.77